Neurodegenerative Diseases
1 competing product in clinical development for Neurodegenerative Diseases.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Latozinemab | Alector | Phase 3 | Terminated | 69 |
1 competing product in clinical development for Neurodegenerative Diseases.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Latozinemab | Alector | Phase 3 | Terminated | 69 |